
Pet treatment getting costly: Here's why having a pet insurance cover can help
Myths among pet parents
Hassle-free claim settlement
No cashless option
Our pets are more than just animals—they're family. They shower us with unconditional love and, in return, we do everything we can to keep them happy and healthy. However, when illness strikes, the emotional toll on pet parents is immense; so is the financial one.Caring for a pet means making sure their health needs are addressed without delay. Yet, many pet parents hesitate to visit a veterinarian, not because they don't care, but because they're worried about the cost.'We did an internal survey and it revealed that many pet owners don't take their pets to the vet, hoping for self-recovery because they can't afford to get them treated,' says Arti Mulik, Chief Technical Officer at Universal Sompo General Insurance (USGI). Pet insurance , though still a niche product in India, can help bridge this gap, offering both financial support and peace of mind during emergencies. Take the case of Gurugram-based Meenakshi Goel, and Peanut and Butter, her two Indie (mixed breed native to India) dogs. After a visit to the vet for one of them left her with a `7,000 bill, she decided to get insurance for both from Bajaj Allianz General Insurance . 'I haven't filed a claim yet, but I sleep better knowing that if something happens, I won't have to choose between treatment and affordability,' she says.Her concern is widely shared. A USGI survey of 235 pet owners found that 90% considered veterinary costs a major burden, while 74% said it caused financial stress. Serious conditions like fractures, chronic illness, or cancer can easily rack up bills ranging from Rs.10,000 to over Rs.1 lakh—expense that could hit hard without a financial cushion.Despite signs of need for insurance, awareness remains low. Only 26% of the surveyed pet parents had heard of pet insurance, and a mere 10% had purchased it. 'Most of the clients who visit our clinic are unaware that such a product exists, even though it can be extremely useful and necessary,' says Dr B.K. Chaudhary, a veterinarian at Dog and Cat Clinic in Delhi.Mulik added that low agent interest is also to blame, explaining, 'The ticket size and premium are small, so agents don't find it attractive from a commission standpoint.'Even if people are aware, misconceptions often keep them from purchasing a policy. Chennai-based A. Thirumaal, a doctor who is a parent to two cats, explored pet insurance, but ultimately decided against it. 'There are too many exclusions, and most plans are designed with dogs in mind. A cat specific product would be more relevant for me,' he says.His main concern is that his cats often wander outdoors and have been seriously injured in fights with stray dogs, an issue that has already cost him two pets. 'I couldn't find any insurance that covers such incidents,' Dr Thirumaal adds. However, his assumption is misplaced. Most insurers offer 'accidental injury cover' that includes such scenarios. A deeper understanding of policy inclusions and exclusions could help pet owners like Dr Thirumaal clear their misunderstandings about what's not covered.The belief that pet insurance comes with too many exclusions is largely unfounded. Some of the pet insurance plans (see table) available in the market cover most of the commonly occurring illnesses like fractures, cancer, or terminal diseases. 'Diseases that are typically excluded from coverage are those rarely found in cats or dogs, except for gastrointestinal issues, which may be covered with extra premium,' says Dr Chaudhary.Insurers also maintain transparency. Exclusions are clearly listed in the policy brochure and are usually communicated during the purchase process. These could include age eligibility, which is a common concern among pet parents. Most insurers cover pets between the ages of three months and seven years, with renewals often allowed up to 11-12 years.Dental treatments are another common exclusion, but it shouldn't be a concern. 'Dogs usually develop dental issues at a much later stage, typically after 13-14 years of age,' says Dr Chaudhary. Given that most policies cap coverage well before that age, excluding dental treatments can be seen as a reasonable limitation.Pet insurers offer standalone covers, which can be customised as per one's need. The premium depends on the type and number of covers you opt for.'There are no real downsides to buying pet insurance. Claim rejection issues are virtually unheard of,' says Arpita Lal, Head of Pet Insurance at Policybazaar.Dr Chaudhary echoed the sentiment, noting that none of his clients faced trouble while filing claims, unless their pet had a pre-existing condition. The problem, he said, usually lies in policyholders being ignorant about a specific visit or issue not being covered. This underscores the importance of reading the fine print and understanding exactly what illnesses and procedures are included. Pet insurance doesn't work like standard health insurance where there the sum insured covers hospitalisation, surgery, etc. Instead, you can choose from several specific covers offered by the insurer. Figuring out which one suits your pet's needs can often be confusing. 'It's advisable to consult a vet to determine which options are best suited for you,' adds Dr Chaudhary. A pet's breed, age, and gender can significantly influence its health needs—and consequently, the insurance premium. For instance, golden retrievers are more prone to cancer-related issues than other breeds. Hence, a terminal illness cover is a must while purchasing insurance for them.One visit to the veterinarian made her realise how costly procedures can be.Peanut and Butter (both 5 years)IndiesBajaj AllianzRs.5,000 yearly for bothOPD, surgery, hospitalisation, mortality,terminal illness, third-party liability.For starters, a typical pet plan offering coverage of up to Rs.2-3 lakh costs around Rs.10,000 a year, which is adequate for most standard veterinary needs. If you find the premium too high, there is also the option of co-payment, where you agree to bear a fixed percentage of the bill, and the insurer covers the rest. The higher the co-pay option you choose, the lower your annual premium.One important thing to note is that cashless claims are not currently offered by any insurer in India. Pet parents need to pay the veterinary costs up front and then file for reimbursement. This process can sometimes take 2-3 months, depending on the claim's complexity.Feels that products are not comprehensive enough to suit the unique needs of a cat, which is a misconception.A. Thirumaal, ChennaiZoe (2.5 years) and Penny (1.5 years)IndiesThe pet insurance industry in India is still at a nascent stage and requires significant improvements before it can cater to a larger segment of customers. At present, most plans cover only cats and dogs. Other pets like birds or rabbits are left out. A survey conducted by pet website, Dogster, found that only a smaller niche of Indian pet parents, around 32,000, owns exotic animals, such as turtles, lemurs and snakes. Unfortunately, they currently have no access to insurance options for their pets.If you fall in this category or feel pet insurance does not align with your needs, it's advisable to maintain an emergency fund dedicated to your pet. This will ensure that any unexpected medical expenses don't strain your budget.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
an hour ago
- Hans India
Services of Roots Health Foundation lauded
Vijayawada: Minister for BC, EWS Welfare, Handlooms and Textiles S Savitha lauded the Roots Health Foundation for its exemplary service to the poor and cancer patients ove r the past 12 years, calling them an inspiration to many. Speaking at the 'Roots Health Service Awards – 2025' event, organised by the Foundation to commemorate Doctor's Day on Sunday at the PB Siddhartha College Auditorium in Moghalrajapuram, the Minister highlighted the extensive medical services provided by the Roots Health Foundation. She commended the Foundation for honoring 82 doctors who have rendered outstanding services in the medical profession over the last 12 years, calling it a positive development that would inspire them to participate more actively in social initiatives. 'I personally witnessed their invaluable services during the Vijayawada floods,' she stated. She noted that Chief Minister Nara Chandrababu Naidu has allocated Rs 20,000 crore in the budget, recognising the paramount importance of the healthcare sector. She reiterated the Chief Minister's resolve to transform the state into 'Arogya Andhra' (Healthy Andhra). Additionally, she mentioned the successful completion of the 'Koti Mokkalu Nate Karyakramam' aimed at making the state Haritha Andhra. She highlighted the 'Yoga Andhra-2025' initiative, which secured a Guinness World Record, as a testament to the government's commitment to public health. She called for similar medical service programs to be undertaken in the Rayalaseema region as well. Vijayawada East Constituency MLA Gadde Rammohan Rao also praised the Roots Health Foundation's unparalleled services in the medical field. He acknowledged the significance of recognising prominent medical professionals with health awards for their contributions to society. During the event, the Roots Health Foundation provided financial assistance of Rs 10,000 to Bhakta Singh, a 12-year-old boy suffering from cancer. The 'Roots Health Service Award-2025' was presented to distinguished doctors for their excellence in the medical profession. State NGO president A. Vidyasagar, Actor Suman, Roots Health Foundation chairman Dr Polavarapu Vijay Bhaskar, Dr Ramana Murthy, Dr Samaram, Dr N Murali Krishna, Siddhartha Medical College Principal AY Rao, Film Chamber Chairman Srinivasa Raju and others and medical students also participated.


New Indian Express
2 hours ago
- New Indian Express
Obesity drug prices are dropping in US, but getting a steady supply remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients. And even for people with insurance, coverage remains uneven. 'The medications should be available, the question is at what price and can people sustain that,' said Matt Maciejewski, a Duke University professor who studies obesity treatment coverage. Doctors say the situation forces them to get creative in treating patients, but there's hope that prices may fall more in the future. The drugs are still in high demand Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity. Zepbound brought in $2.3 billion in U.S. sales during this year's first quarter, making it one of drugmaker Eli Lilly's best sellers. Novo Nordisk says Wegovy has about 200,000 weekly prescriptions in the U.S., where it brought in nearly $1.9 billion in first-quarter sales. Insurance coverage is increasing — for some The benefits consultant Mercer says more businesses with 500 or more employees are adding coverage of the injected drugs for their workers and family members. And Novo says 85% of its patients who have coverage in the U.S. pay $25 or less per month. Plus some patients with diabetes can get coverage of the GLP-1 drugs Ozempic and Mounjaro from Novo and Lilly that are approved to treat that condition. But most state and federally funded Medicaid programs don't cover the drugs for obesity and neither does Medicare, the federal program mainly for people age 65 and older. Even the plans that cover the drugs often pay only a portion of the bill, exposing patients to hundreds of dollars in monthly costs, said Dr. Beverly Tchang. Drugmakers offer help with these out-of-pocket costs, but that assistance can be limited. 'Coverage is not the same as access,' said Tchang, a New York-based doctor who serves as a paid advisor to both Novo and Lilly. But coverage remains inconsistent Bill-payers like employers are nervous about drugs that might be used by a lot of people indefinitely. Some big employers have dropped coverage of the drugs due to the expense. Pharmacy benefit managers, or PBMs, also are starting to pick one brand over the other as they negotiate deals with the drugmakers. One of the nation's largest PBMs, run by CVS Health, dropped Zepbound from its national formulary, or list of covered drugs, on July 1 in favor of Wegovy. That forced Tchang to figure out another treatment plan for several patients, many of whom took Zepbound because it made them less nauseous. Dr. Courtney Younglove's office sends prospective patients a video link showing them how to check their insurer's website for coverage of the drugs before they visit. 'Then some of them just cancel their appointment because they don't have coverage,' the Overland Park, Kansas, doctor said. Cheaper compounded drugs are still being sold Compounding pharmacies and other entities were allowed to make off-brand, cheaper copies of Wegovy and Zepbound when there was a shortage of the drugs. But the U.S. Food and Drug Administration determined earlier this year that the shortage had ended. That should have ended the compounded versions, but there is an exception: Some compounding is permitted when a drug is personalized for the patient.


Indian Express
2 hours ago
- Indian Express
IIT Delhi introduces online executive programme for AI in Healthcare
The Indian Institute of Technology, Delhi and edtech company TeamLease, has introduced a new online executive programme on AI in Healthcare. Designed for clinicians, engineers, data professionals, and med-tech entrepreneurs, this 24-week programme equips participants with future-ready skills to drive innovation in patient care, diagnostics, public health, and hospital operations. The online programme offers an academic and practical foundation in AI for healthcare. Participants gain hands-on experience with clinical datasets, explore hospital data systems, and learn to build AI models for diagnosis, risk scoring, imaging, and predictive analytics. The fee of the course is Rs 1.20 lakh + 18 per cent GST. IIT Delhi Scholarships Any graduate professional working in industry and academia with an area relevant to AI in healthcare is eligible for the course. The application link for the course registration is Know other IIT Delhi courses After completing the course, students can expect the following employment opportunities: –AI/ML Engineer – Design and develop AI models for diagnostics, disease prediction, or medical imaging –Healthcare Data Scientist – Analyze clinical data to generate insights and predict patient outcomes –Clinical AI Researcher – Conduct research and validation of AI tools in real-world healthcare settings –Digital Health Consultant – Guide healthcare providers in adopting AI solutions for improved care and efficiency –Medical Imaging Analyst – Use AI to interpret X-rays, MRIs, and CT scans with greater speed and accuracy –AI Product Manager – HealthTech – Oversee development and deployment of AI-based healthcare products –Regulatory/Data Governance Specialist – Ensure AI models meet healthcare data privacy and compliance standards The course will start in November. The course will be delivered via live, interactive online sessions on weekends, ensuring flexibility for working professionals.